rs34661029

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001291746.2(REL):​c.1082C>G​(p.Pro361Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00102 in 1,614,094 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P361T) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0056 ( 7 hom., cov: 32)
Exomes 𝑓: 0.00054 ( 5 hom. )

Consequence

REL
NM_001291746.2 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.02

Publications

3 publications found
Variant links:
Genes affected
REL (HGNC:9954): (REL proto-oncogene, NF-kB subunit) This gene encodes a protein that belongs to the Rel homology domain/immunoglobulin-like fold, plexin, transcription factor (RHD/IPT) family. Members of this family regulate genes involved in apoptosis, inflammation, the immune response, and oncogenic processes. This proto-oncogene plays a role in the survival and proliferation of B lymphocytes. Mutation or amplification of this gene is associated with B-cell lymphomas, including Hodgkin's lymphoma. Single nucleotide polymorphisms in this gene are associated with susceptibility to ulcerative colitis and rheumatoid arthritis. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Apr 2014]
REL Gene-Disease associations (from GenCC):
  • immunodeficiency 92
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003190726).
BP6
Variant 2-60921853-C-G is Benign according to our data. Variant chr2-60921853-C-G is described in ClinVar as Benign. ClinVar VariationId is 790504.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00564 (859/152228) while in subpopulation AFR AF = 0.0197 (820/41534). AF 95% confidence interval is 0.0186. There are 7 homozygotes in GnomAd4. There are 388 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 7 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RELNM_001291746.2 linkc.1082C>G p.Pro361Arg missense_variant Exon 10 of 10 ENST00000394479.4 NP_001278675.1 Q04864-2
RELNM_002908.4 linkc.1178C>G p.Pro393Arg missense_variant Exon 11 of 11 NP_002899.1 Q04864-1
RELNM_001438025.1 linkc.1013C>G p.Pro338Arg missense_variant Exon 9 of 9 NP_001424954.1
RELXM_011533010.4 linkc.788C>G p.Pro263Arg missense_variant Exon 8 of 8 XP_011531312.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RELENST00000394479.4 linkc.1082C>G p.Pro361Arg missense_variant Exon 10 of 10 1 NM_001291746.2 ENSP00000377989.4 Q04864-2

Frequencies

GnomAD3 genomes
AF:
0.00561
AC:
854
AN:
152110
Hom.:
7
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0197
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00190
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00147
AC:
369
AN:
251294
AF XY:
0.00105
show subpopulations
Gnomad AFR exome
AF:
0.0204
Gnomad AMR exome
AF:
0.000752
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000704
Gnomad OTH exome
AF:
0.000490
GnomAD4 exome
AF:
0.000539
AC:
788
AN:
1461866
Hom.:
5
Cov.:
32
AF XY:
0.000477
AC XY:
347
AN XY:
727234
show subpopulations
African (AFR)
AF:
0.0188
AC:
628
AN:
33480
American (AMR)
AF:
0.00105
AC:
47
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53412
Middle Eastern (MID)
AF:
0.000693
AC:
4
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000351
AC:
39
AN:
1111998
Other (OTH)
AF:
0.00113
AC:
68
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
49
98
147
196
245
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00564
AC:
859
AN:
152228
Hom.:
7
Cov.:
32
AF XY:
0.00521
AC XY:
388
AN XY:
74434
show subpopulations
African (AFR)
AF:
0.0197
AC:
820
AN:
41534
American (AMR)
AF:
0.00190
AC:
29
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10602
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
68026
Other (OTH)
AF:
0.00284
AC:
6
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
45
89
134
178
223
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000898
Hom.:
0
Bravo
AF:
0.00648
ESP6500AA
AF:
0.0211
AC:
93
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.00180
AC:
219
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.62
T
BayesDel_noAF
Benign
-0.64
CADD
Benign
17
DANN
Uncertain
0.98
DEOGEN2
Benign
0.12
T;.
Eigen
Benign
-0.47
Eigen_PC
Benign
-0.29
FATHMM_MKL
Benign
0.30
N
LIST_S2
Benign
0.70
T;T
MetaRNN
Benign
0.0032
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.34
N;.
PhyloP100
1.0
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-1.5
N;N
REVEL
Benign
0.034
Sift
Benign
0.11
T;T
Sift4G
Benign
0.37
T;T
Polyphen
0.18
B;.
Vest4
0.085
MVP
0.12
MPC
0.027
ClinPred
0.0066
T
GERP RS
3.6
Varity_R
0.049
gMVP
0.24
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34661029; hg19: chr2-61148988; COSMIC: COSV54363101; API